Cancer pain in children and adolescents
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 7
Abstract
As far as population of growth age is concerned, every year, in Poland there are 1100 to 1300 new cases of going down with cancer. The most common cases are leukemia, tumour, lymphoma (59.3% of all children’s cancer cases). Current treatment is based on multidrug chemotherapy, which is the basis of the oncological treatment. Radiotherapy and surgery are only supplementary methods. Pain is an integral part of cancer disease. “Cancer pain” is used to describe pain caused by cancer which occurs as a result of antitumour therapy and both situations simultaneously. Difficulty of estimation of occurrence frequency and pain intensity as far as children of different ages are concerned resulted in development of many scales. Current methods of estimation of pain intensity are based on nonverbal information and verbal one, which describe pain features. More than one instrument should be used to make the estimation valid. Each scale should be earlier explained to the patient. Visual Analogue Scale- VAS is the basic scale and it is used to estimate pain as far as children over 5 years old are concerned. Number Rating Scale – NRS is a variety of VAS. It is suitable for children over 7 years old, as well as Verbal Rating Scale VRS (word scale) and scale according to Oucher. In the latter, pictures of child’s faces are used. Maps of pain are an additional source of information about pain – a child ticks places which hurt. APPT is a self-report instrument for children aged 7-17. DEGR is a behavioural-observational scale which was created to estimate long lasting pain as far as children aged 2-6 are concerned. AOB – a form which contains a number of words describing pain which the patient is currently suffering from or the last pain. The form is suitable for children over 11 years old and it contains pain estimation in quantitative and qualitative categories
Authors and Affiliations
Mirosława Kram, Andrzej Kurylak
Rola mikroRNA w patogenezie, diagnostyce i terapii nowotworów
Artykuł ten przedstawia w zarysie aktualny stan wiedzy w zakresie biogenezy, mechanizmu działania oraz funkcji fizjologicznej mikroRNA, niedawno odkrytych, bardzo ważnych regulatorów procesów proliferacji komórek, ich ró...
Telomer i telomeraza w onkogenezie
Telomer to jednostka strukturalno-funkcjonalna obecna na końcach chromosomów. W ostatnich latach, dzięki lepszemu poznaniu budowy i funkcji telomeru i telomerazy wzrosło ich znaczenie w zrozumieniu procesu nowotworzenia....
The prognostic value of cytokine levels in patients with cancer
We have demonstrated that the serum levels of many cytokines and soluble cytokine receptors are increased in a great proportion of patients with ovarian cancer, colorectal cancer, non-small cell lung carcinoma and soft t...
Advances in the management of malignant glinoma recurrence
Since virtually all malignant gliomas relapse after primary treatment the management of relapsing glioma is a common clinical dilemma. Before making a decision on choice of surgery, chemotherapy or radiotherapy as a tr...
Połączenie pozytonowej tomografii emisyjnej z tomografią komputerową (PET/CT) w ocenie stopnia zaawansowania raku przełyku – analiza 12 przypadków
Pozytonowa tomografia emisyjna (PET) z użyciem F-18-fluorodeoksyglukozy (FDG) znajduje coraz szersze zastosowanie w rozpoznawaniu i leczeniu nowotworów. Połączenie badania FDG-PET z tomografią komputerową (CT) zwiększa m...